Actively Recruiting
Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2024-10-26
83
Participants Needed
1
Research Sites
266 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective is to evaluate the concordance of FDG PET/CT and total body DWI MRI sequences performed during staging and at the completion of therapy. Specifically, we will assess the positivity rates, both patient-based and lesion-based (total and by district), of the two methods during staging and at the completion of therapy. An interim analysis will be conducted comparing the two methods, followed by a final prognostic analysis.
CONDITIONS
Official Title
Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with symptomatic myeloma in the staging phase or suspected symptomatic myeloma in the diagnostic phase
- Patients who have signed the informed consent form
You will not qualify if you...
- Patients with other active cancers or with a history of cancer in the past 5 years
- Age under 18 years
- Women who are breastfeeding or pregnant
- Patients with metal implants or devices that prevent MRI
- Patients with severe claustrophobia
- Patients with bone pain that prevents lying still in the supine position for a long time
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Policlinico S.Orsola Malpighi
Bologna, Italy, 40138
Actively Recruiting
Research Team
C
CRISTINA NANNI, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here